Aprea Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.82

+0.03 (+3.67%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +4,302.9% upside

Low Target $23.45

Average Target $36.06

High Target $38.88

Current Price $0.82

Current
$0.82

Target
$36.06

$23.45 $36.06 avg $38.88

Scenario Analysis

Bear Case

$23.45

2,763.2%

Low target

Base Case

$36.06

+4,302.9%

Avg target

Bull Case

$38.88

+4,647.3%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$2.22

-63.1% from high

52-Week Low

$0.55

+49.5% from low

Target vs 52W High

$36.06

+1,524.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.2%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.6%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-38.5%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.0%